• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD OPTIFLOW + ADULT NASAL CANNULA; BTT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD OPTIFLOW + ADULT NASAL CANNULA; BTT Back to Search Results
Model Number OPT944
Device Problems Break (1069); Material Split, Cut or Torn (4008)
Patient Problem Low Oxygen Saturation (2477)
Event Date 01/10/2022
Event Type  Death  
Manufacturer Narrative
(b)(4).Fisher & paykel healthcare (f&p) is currently in the process of retrieving further information regarding the reported event.We will provide a follow up report upon completion of our investigation.
 
Event Description
A healthcare facility in france reported via a fisher & paykel healthcare (f&p) field representative that the tubing of an opt944 optiflow + adult nasal cannula was found damaged during use on a covid-19 patient.The patient desaturated and the subject cannula was removed and replaced with another opt944 nasal cannula.It was reported that the patient deceased approximately 5 minutes later.The healthcare facility noted that the patient was at the end of life.Further information has been requested regarding the reported event and the medical cause of death.
 
Manufacturer Narrative
(b)(4).The opt944 optiflow + adult nasal cannula is an interface used to deliver humidified oxygen to patients and consists of a lightweight delivery tube connected to a rigid plastic base and soft nasal prongs (nasal interface).This allows the device to be light weight and durable.The interface is held in place by a head strap and features a head strap clip which works in tandem with the tubing clip (attaches to the patient's clothing/bedding) to support the weight of the circuit and prevent the cannula being dislodged.Method: the complaint opt944 optiflow + adult nasal cannula was returned to fisher & paykel healthcare (f&p) new zealand for investigation, where it was visually inspected.Several attempts to request further information from healthcare facility were also made, however no response was provided by the healthcare facility.Results: visual inspection of the returned cannula revealed that the tubing was stretched and torn.Further information about the reported incident and the medical cause of death was requested but was not provided.Conclusion: we are unable to determine the cause of the reported event.However based on our knowledge of the product and our observation that the tubing was stretched and torn, the reported event was likely caused by the cannula being subjected to excessive force.It should be noted that the patient was covid-19 positive and was at the end of life.All optiflow interfaces are inspected during production for visual defects including cracks, tears, inclusions, discoloration and stretching or deformation.Any product that fails the visual inspection is disposed of.The subject opt944 optiflow + adult nasal cannula would have met the required specifications.The user instructions which accompany the opt944 optiflow + adult nasal cannula show in pictorial format the correct placement and fitting of the cannula, including ensuring the headstrap clip and the tubing clip are appropriately attached.The user instructions also warn: "ensure head strap clip is attached, to prevent cannula from being pulled out of the nares." "cannula can become unattached if not used with the head strap clip." "attach tubing clip to clothing/bedding to prevent cannula from pulling off face." "appropriate patient monitoring must be used at all times.Failure to monitor the patient may result in loss of therapy, serious injury or death." "do not crush or stretch tube, to prevent loss of therapy." "failure to use the set-up described above can compromise performance and affect patient safety.".
 
Event Description
A healthcare facility in france reported via a fisher & paykel healthcare (f&p) field representative that the tubing of an opt944 optiflow + adult nasal cannula was found damaged during use on a covid-19 patient.The patient desaturated and the subject cannula was removed and replaced with another opt944 nasal cannula.It was reported that the patient deceased approximately 5 minutes later.The healthcare facility noted that the patient was at the end of life.Further information about the reported incident and the medical cause of death was requested from the healthcare facility.However, the healthcare facility did not provide any of the requested information despite several attempts to request this.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLOW + ADULT NASAL CANNULA
Type of Device
BTT
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
faranak gomarooni
173 technology drive
suite 100
irvine, CA 92618
9494534002
MDR Report Key13502520
MDR Text Key285387396
Report Number9611451-2022-00134
Device Sequence Number1
Product Code BTT
UDI-Device Identifier09420012429117
UDI-Public(01)09420012429117(10)2101417545(11)201202
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K162553
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 01/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberOPT944
Device Catalogue NumberOPT944
Device Lot Number2101417545
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/24/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/11/2022
Initial Date FDA Received02/09/2022
Supplement Dates Manufacturer Received03/20/2022
Supplement Dates FDA Received04/13/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/02/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
F&P PT101 AIRVO 2 HUMIDIFIER; F&P PT101 AIRVO 2 HUMIDIFIER
Patient Outcome(s) Death;
Patient Age58 YR
-
-